SYBT
NVO

Stock Yards Bank & Trust’s Novo Nordisk NVO Stock Holding History

Stock Yards Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,696
Closed -$255K – 394
2025
Q2 		$255K Sell
3,696
-651
-15% -$44.3K 0.01% 349
2025
Q1 		$302K Sell
4,347
-257
-6% -$21.2K 0.01% 324
2024
Q4 		$396K Buy
4,604
+651
+16% +$70.4K 0.01% 297
2024
Q3 		$471K Hold
3,953
– – 0.02% 281
2024
Q2 		$564K Hold
3,953
– – 0.02% 259
2024
Q1 		$508K Buy
3,953
+667
+20% +$79.4K 0.02% 278
2023
Q4 		$340K Buy
3,286
+24
+0.7% +$2.37K 0.01% 316
2023
Q3 		$297K Buy
3,262
+400
+14% +$35.2K 0.01% 325
2023
Q2 		$232K Hold
2,862
– – 0.01% 364
2023
Q1 		$228K Buy
+2,862
New +$203K 0.01% 369
2017
Q3 		– Sell
-14,160
Closed -$303K – 221
2017
Q2 		$303K Sell
14,160
-17,910
-56% -$361K 0.04% 171
2017
Q1 		$549K Sell
32,070
-443,510
-93% -$7.72M 0.07% 129
2016
Q4 		$8.53M Sell
475,580
-14,420
-3% -$261K 1.12% 37
2016
Q3 		$10.2M Buy
490,000
+3,158
+0.6% +$78.3K 1.39% 26
2016
Q2 		$13.1M Sell
486,842
-82,056
-14% -$2.25M 1.74% 15
2016
Q1 		$15.4M Buy
568,898
+2,366
+0.4% +$63.4K 2.2% 7
2015
Q4 		$16.5M Buy
566,532
+2,134
+0.4% +$59.1K 2.29% 5
2015
Q3 		$15.3M Sell
564,398
-9,660
-2% -$274K 2.34% 4
2015
Q2 		$15.7M Sell
574,058
-5,564
-1% -$156K 2.23% 7
2015
Q1 		$15.5M Buy
579,622
+9,544
+2% +$220K 2.19% 8
2014
Q4 		$12.1M Buy
570,078
+102,418
+22% +$2.29M 1.71% 15
2014
Q3 		$11.1M Sell
467,660
-19,444
-4% -$447K 1.69% 16
2014
Q2 		$11.3M Buy
487,104
+116
+0% +$2.56K 1.59% 18
2014
Q1 		$11.1M Buy
486,988
+3,978
+0.8% +$84.8K 1.61% 20
2013
Q4 		$8.92M Buy
483,010
+550
+0.1% +$9.59K 1.33% 28
2013
Q3 		$8.16M Sell
482,460
-340,020
-41% -$5.72M 1.31% 32
2013
Q2 		$12.7M Buy
+822,480
New +$13.7M 1.42% 33

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stock Yards Bank & Trust's NVO Position: Q3 2025 in Review

Stock Yards Bank & Trust sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,696 shares — an estimated $255K sold.

Stock Yards Bank & Trust first reported a position in NVO in Q2 2013 and held it in 27 quarters. The position peaked at $16.5M in Q4 2015. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Stock Yards Bank & Trust reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Stock Yards Bank & Trust sold 3,696 Novo Nordisk shares in Q3 2025, an estimated $255K.
  • Stock Yards Bank & Trust first reported a position in Novo Nordisk in Q2 2013 and held it in 27 quarters.
  • Stock Yards Bank & Trust's Novo Nordisk position peaked at $16.5M in Q4 2015.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Stock Yards Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.